Intake of Soy, Soy Isoflavones and Soy Protein and Risk of Cancer Incidence and Mortality.

Yahui Fan, Mingxu Wang, Zhaofang Li, Hong Jiang, Jia Shi, Xin Shi, Sijiao Liu, Jinping Zhao, Liyun Kong, Wei Zhang, Le Ma
Author Information
  1. Yahui Fan: The First Affiliated Hospital, Xi'an Jiaotong University Health Science Center, Xi'an, China.
  2. Mingxu Wang: School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
  3. Zhaofang Li: School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
  4. Hong Jiang: School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
  5. Jia Shi: School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
  6. Xin Shi: School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
  7. Sijiao Liu: School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
  8. Jinping Zhao: School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
  9. Liyun Kong: School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
  10. Wei Zhang: The First Affiliated Hospital, Xi'an Jiaotong University Health Science Center, Xi'an, China.
  11. Le Ma: School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.

Abstract

Background and Aims: Associations between soy intake and risk of cancer have been evaluated in prospective observational studies with inconsistent results. Whether the potential anticancer effects offered by soy were attributed to soy isoflavones and soy protein still needs to be elucidated. This study aimed to comprehensively quantify the association of soy, soy isoflavones and soy protein intake with risk of cancer incidence and cancer mortality by conducting a meta-analysis of all available studies.
Methods: PubMed, Embase, Web of Science, and Cochrane Library databases were searched up to 16 September 2021. Prospective cohort studies that examined the effect of soy, soy isoflavones and soy protein on cancer incidence and cancer mortality were identified. Random-effects models were used to pool the multivariable-adjusted relative risks (RRs) and corresponding 95% confidence intervals (CIs). The potential dose-response relations were explored by using generalized least-squares trend estimation.
Results: Eighty one prospective cohort studies were included in the meta-analysis. A higher intake of soy was significantly associated with a 10% reduced risk of cancer incidence (RR, 0.90; 95% CI, 0.83-0.96). Each additional 25 g/d soy intake decreased the risk of cancer incidence by 4%. Intake of soy isoflavones was inversely associated with risk of cancer incidence (RR, 0.94; 95% CI, 0.89-0.99), whereas no significant association was observed for soy protein. The risk of cancer incidence was reduced by 4% with each 10 mg/d increment of soy isoflavones intake. Similar inverse associations were also found for soy in relation to site-specific cancers, particularly lung cancer (RR, 0.67; 95%CI, 0.52-0.86) and prostate cancer (RR, 0.88; 95%CI, 0.78-0.99). However, high intake of soy, soy isoflavones and soy protein were not associated with cancer mortality.
Conclusions: Higher intake of soy and soy isoflavones were inversely associated with risk of cancer incidence, which suggested that the beneficial role of soy against cancer might be primarily attributed to soy isoflavones. These findings support recommendations to include soy as part of a healthy dietary pattern for the prevention of cancer.

Keywords

References

  1. J Epidemiol. 2013 Sep 5;23(5):337-43 [PMID: 23812102]
  2. Am J Clin Nutr. 2009 Feb;89(2):577-83 [PMID: 19073792]
  3. Int J Health Geogr. 2010 Apr 21;9:19 [PMID: 20409297]
  4. Nutr Rev. 2021 Jan 1;79(1):42-65 [PMID: 32632445]
  5. Br J Cancer. 2002 Jul 1;87(1):37-42 [PMID: 12085253]
  6. Biofactors. 2016 Nov 12;42(6):623-637 [PMID: 27255553]
  7. Am J Epidemiol. 2007 Apr 1;165(7):802-13 [PMID: 17210953]
  8. Int J Cancer. 2015 Aug 15;137(4):885-92 [PMID: 25639758]
  9. Cancers (Basel). 2011 Apr 28;3(2):2214-22 [PMID: 24212805]
  10. Eur J Clin Nutr. 2016 Jan;70(1):41-6 [PMID: 26330148]
  11. Stat Med. 2002 Jun 15;21(11):1539-58 [PMID: 12111919]
  12. Cancer Causes Control. 2005 Sep;16(7):773-80 [PMID: 16132787]
  13. Am J Clin Nutr. 2009 Mar;89(3):905-12 [PMID: 19158208]
  14. J Natl Cancer Inst. 2007 Aug 1;99(15):1200-9 [PMID: 17652276]
  15. Br J Nutr. 2014 Sep 28;112(6):976-83 [PMID: 25201305]
  16. Am J Clin Nutr. 2010 Apr;91(4):1013-9 [PMID: 20181808]
  17. Am J Clin Nutr. 2012 Jul;96(1):123-32 [PMID: 22648714]
  18. Eur J Nutr. 2021 Apr;60(3):1389-1401 [PMID: 32719984]
  19. J Epidemiol. 2005 Jun;15 Suppl 2:S98-108 [PMID: 16127240]
  20. Nutrients. 2016 Nov 24;8(12): [PMID: 27886135]
  21. Am J Clin Nutr. 2010 Mar;91(3):722-8 [PMID: 20071645]
  22. Cancer Metastasis Rev. 2002;21(3-4):265-80 [PMID: 12549765]
  23. Int J Epidemiol. 2020 Oct 1;49(5):1553-1561 [PMID: 32968784]
  24. Sci Rep. 2017 Jun 22;7(1):4048 [PMID: 28642459]
  25. BMJ. 2020 Jan 29;368:m34 [PMID: 31996350]
  26. Int J Cancer. 2016 Aug 15;139(4):742-8 [PMID: 27038352]
  27. Cancer Chemother Pharmacol. 2012 Sep;70(3):425-37 [PMID: 22814678]
  28. Int J Cancer. 2018 Feb 15;142(4):719-728 [PMID: 29114854]
  29. Nutr Cancer. 2016;68(3):388-95 [PMID: 27010988]
  30. Br J Nutr. 2019 Sep 14;122(5):564-574 [PMID: 30526696]
  31. Cancer. 2010 Jul 1;116(13):3119-26 [PMID: 20564627]
  32. J Nutr. 2008 May;138(5):938-45 [PMID: 18424605]
  33. Cancer Causes Control. 1998 Dec;9(6):553-7 [PMID: 10189040]
  34. BMC Cancer. 2019 Jan 3;19(1):6 [PMID: 30606143]
  35. Cancer Res. 1989 Apr 1;49(7):1857-60 [PMID: 2924323]
  36. Br J Cancer. 2014 Oct 28;111(9):1870-80 [PMID: 25121955]
  37. Int J Cancer. 2008 Aug 1;123(3):664-71 [PMID: 18491403]
  38. Am J Epidemiol. 2002 Nov 1;156(9):824-31 [PMID: 12397000]
  39. Br J Cancer. 2008 Nov 4;99(9):1511-6 [PMID: 18813309]
  40. Nutrients. 2018 Jan 05;10(1): [PMID: 29304010]
  41. Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2277-9 [PMID: 15598793]
  42. Am J Epidemiol. 2012 Nov 15;176(10):846-55 [PMID: 23097255]
  43. Mol Cancer Res. 2006 Apr;4(4):221-33 [PMID: 16603636]
  44. Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):821-7 [PMID: 19240237]
  45. Circulation. 2006 Feb 21;113(7):1034-44 [PMID: 16418439]
  46. Biomed Res Int. 2014;2014:608979 [PMID: 24527452]
  47. Atherosclerosis. 2017 Aug;263:343-351 [PMID: 28624099]
  48. Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2285-92 [PMID: 18006917]
  49. Nutr Cancer. 2007;57(2):138-45 [PMID: 17571946]
  50. Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1674-7 [PMID: 12496060]
  51. Eur J Epidemiol. 2020 Jun;35(6):567-578 [PMID: 31754945]
  52. Circulation. 2020 Apr 7;141(14):1127-1137 [PMID: 32200662]
  53. Mol Nutr Food Res. 2013 Feb;57(2):249-59 [PMID: 23255485]
  54. Int J Cancer. 2008 Aug 15;123(4):927-32 [PMID: 18521907]
  55. J Health Popul Nutr. 2019 Nov 27;38(1):36 [PMID: 31775902]
  56. J Natl Cancer Inst. 2012 Jan 4;104(1):67-76 [PMID: 22158125]
  57. Jpn J Cancer Res. 1992 Jun;83(6):568-75 [PMID: 1644660]
  58. Am J Clin Nutr. 2004 Feb;79(2):282-8 [PMID: 14749235]
  59. Int J Cancer. 1996 May 3;66(3):309-14 [PMID: 8621249]
  60. Cancer Causes Control. 2004 Nov;15(9):911-20 [PMID: 15577293]
  61. Cancer Sci. 2020 Jul;111(7):2558-2569 [PMID: 32412140]
  62. Int J Cancer. 2008 Feb 1;122(3):705-10 [PMID: 17943732]
  63. Br J Cancer. 1999 Dec;81(7):1248-56 [PMID: 10584890]
  64. Kurume Med J. 2004;51(2):141-9 [PMID: 15373231]
  65. Nutr Cancer. 2007;57(2):151-7 [PMID: 17571948]
  66. Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):538-45 [PMID: 17337648]
  67. Jpn J Cancer Res. 2001 Dec;92(12):1259-69 [PMID: 11749690]
  68. Int J Epidemiol. 1998 Apr;27(2):173-80 [PMID: 9602395]
  69. Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2128-35 [PMID: 18708407]
  70. Breast Cancer Res Treat. 2015 Nov;154(2):389-401 [PMID: 26531755]
  71. BJOG. 2015 Feb;122(3):304-11 [PMID: 24941880]
  72. Mol Carcinog. 2006 Dec;45(12):943-56 [PMID: 16865672]
  73. Curr Opin Pharmacol. 2009 Apr;9(2):139-45 [PMID: 19157984]
  74. Circulation. 2007 Nov 27;116(22):2553-62 [PMID: 18025534]
  75. Am J Epidemiol. 1992 Jun 1;135(11):1301-9 [PMID: 1626547]
  76. Cancer Epidemiol Biomarkers Prev. 2018 Nov;27(11):1371-1375 [PMID: 30131436]
  77. Cancer Treat Res Commun. 2021;27:100350 [PMID: 33770661]
  78. JAMA. 2000 Apr 19;283(15):2008-12 [PMID: 10789670]
  79. Int J Epidemiol. 2020 Oct 1;49(5):1526-1537 [PMID: 32095830]
  80. Nutr Cancer. 2013;65(4):527-37 [PMID: 23659444]
  81. Am J Clin Nutr. 2012 Jan;95(1):147-54 [PMID: 22170362]
  82. Int J Mol Sci. 2018 Jun 21;19(7): [PMID: 29933606]
  83. Asian Pac J Cancer Prev. 2007;8 Suppl:35-80 [PMID: 18260705]
  84. Food Funct. 2018 May 23;9(5):2576-2588 [PMID: 29666853]
  85. Cancer Causes Control. 2019 Aug;30(8):847-857 [PMID: 31154549]
  86. J Nutr. 2013 Nov;143(11):1736-42 [PMID: 23986366]
  87. Cancer Causes Control. 2007 Oct;18(8):801-8 [PMID: 17619154]
  88. Int J Cancer. 2004 Nov 1;112(2):319-23 [PMID: 15352046]
  89. J Nutr. 2000 Apr;130(4):798-801 [PMID: 10736332]
  90. J Nutr. 1999 Oct;129(10):1820-6 [PMID: 10498753]
  91. Cancer Causes Control. 2002 Jun;13(5):407-15 [PMID: 12146845]
  92. Nutrients. 2018 Jan 04;10(1): [PMID: 29300347]
  93. Asia Pac J Public Health. 2015 Jul;27(5):531-41 [PMID: 24958613]
  94. Br J Cancer. 2002 Jul 1;87(1):31-6 [PMID: 12085252]
  95. Jpn J Clin Oncol. 2004 Feb;34(2):86-9 [PMID: 15067102]
  96. Cancer Epidemiol Biomarkers Prev. 2020 Jun;29(6):1214-1221 [PMID: 32169996]
  97. Epidemiology. 2013 Sep;24(5):726-33 [PMID: 23881072]
  98. Ann Oncol. 2010 Feb;21(2):263-268 [PMID: 19889614]
  99. Eur J Clin Nutr. 2021 Jun;75(6):954-968 [PMID: 32887936]
  100. BMJ. 2016 Jun 14;353:i2716 [PMID: 27301975]
  101. J Gastroenterol Hepatol. 2006 Nov;21(11):1681-6 [PMID: 16984589]
  102. Int J Cancer. 2013 Aug 15;133(4):952-60 [PMID: 23389819]
  103. Asian Pac J Cancer Prev. 2004 Jan-Mar;5(1):58-65 [PMID: 15075007]
  104. Am J Epidemiol. 2014 Apr 15;179(8):974-86 [PMID: 24567173]
  105. J Epidemiol. 2016;26(2):92-7 [PMID: 26477994]
  106. Am J Clin Nutr. 2020 Mar 1;111(3):677-688 [PMID: 31915830]
  107. Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):308-17 [PMID: 21098648]
  108. Cancer Med. 2021 Jan;10(2):757-771 [PMID: 33340281]
  109. Med Oncol. 2012 Mar;29(1):349-57 [PMID: 21132400]
  110. Cancers (Basel). 2020 Jun 22;12(6): [PMID: 32580490]
  111. Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2574-6 [PMID: 17164390]
  112. Prev Med. 2006 Jul;43(1):20-6 [PMID: 16631248]
  113. Cancer Res. 1990 Feb 1;50(3):627-31 [PMID: 2297702]

Word Cloud

Created with Highcharts 10.0.0soycancerisoflavones0intakeriskincidenceproteinstudiesassociatedRRmortalitymeta-analysis95%SoyprospectivepotentialattributedassociationcohortreducedCI4%Intakeinversely9995%CIBackgroundAims:AssociationsevaluatedobservationalinconsistentresultsWhetheranticancereffectsofferedstillneedselucidatedstudyaimedcomprehensivelyquantifyconductingavailableMethods:PubMedEmbaseWebScienceCochraneLibrarydatabasessearched16September2021ProspectiveexaminedeffectidentifiedRandom-effectsmodelsusedpoolmultivariable-adjustedrelativerisksRRscorrespondingconfidenceintervalsCIsdose-responserelationsexploredusinggeneralizedleast-squarestrendestimationResults:Eightyoneincludedhighersignificantly10%9083-096additional25g/ddecreased9489-0whereassignificantobserved10mg/dincrementSimilarinverseassociationsalsofoundrelationsite-specificcancersparticularlylung6752-086prostate8878-0HoweverhighConclusions:HighersuggestedbeneficialrolemightprimarilyfindingssupportrecommendationsincludeparthealthydietarypatternpreventionIsoflavonesProteinRiskCancerIncidenceMortality

Similar Articles

Cited By